Kamil Adasiewicz
Kamil Adasiewicz has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Agnieszka Klusek
Celon Pharma S.A., Research and Development Center, 15 Marymoncka, 05-152 Kazuń Nowy, Poland
1 shared publication - Andżelika Bystrzejewska
Celon Pharma S.A., Research and Development Center, 15 Marymoncka, 05-152 Kazuń Nowy, Poland
1 shared publication - Ewelina Juszczyk
Research and Development Center, Celon Pharma S.A., Marymoncka 15, 05-152 Kazuń Nowy, Poland
1 shared publication - Jakub Dariusz Kałdowski1 shared publication
- Karolina KęPińska1 shared publication
- Maciej Wieczorek
Celon Pharma S.A., Research and Development Center, 15 Marymoncka, 05-152 Kazuń Nowy, Poland
1 shared publication
Latest Publications
- Open Access
- 7 September 2026
- Published by Polish Pharmaceutical Society in Acta Poloniae Pharmaceutica - Drug Research
- Vol. 83 (3) , 303-316
Green and High-Throughput Quantification of Semaglutide in Bulk Substance and Solutions for Injections Using Liquid Chromatography
A rapid and robust reversed-phase high-performance liquid chromatography (RP-HPLC) method was developed and fully validated strictly as a quantitative assay for the high-throughput determination of semaglutide (SMG) in both active pharmaceutical ingredient (API) powder and solutions for injection. Chromatographic separation was achieved on a Phenomenex Aeris™ 3.6 µm Widepore XB-C18 column (150 × 2.1 mm) using a mobile phase consisting of 100 mM ammonium dihydrogen phosphate buffer combined with acetonitrile , with the addition of perchloric acid using an isocratic elution. The advantage of the developed methodology is the compression of the total run time to 6 minutes, which introduces an over three-fold increase in throughput compared to existing methods. The method was successfully validated according to ICH Q2(R2) , showing specificity, linearity (R2 = 0.998 within 70%–130% range), precision (%RSD ≤ 1.73%) and accurate recovery (98.8% – 100.2%) for bulk and final formulation samples.
- 7 September 2026
- Published by Polish Pharmaceutical Society in Acta Poloniae Pharmaceutica - Drug Research
- Vol. 83 (3) , 303-316
Open AccessGreen and High-Throughput Quantification of Semaglutide in Bulk Substance and Solutions for Injections Using Liquid Chromatography
A rapid and robust reversed-phase high-performance liquid chromatography (RP-HPLC) method was developed and fully validated strictly as a quantitative assay for the high-throughput determination of semaglutide (SMG) in both active pharmaceutical ingredient (API) powder and solutions for injection. Chromatographic separation was achieved on a Phenomenex Aeris™ 3.6 µm Widepore XB-C18 column (150 × 2.1 mm) using a mobile phase consisting of 100 mM ammonium dihydrogen phosphate buffer combined with acetonitrile , with the addition of perchloric acid using an isocratic elution. The advantage of the developed methodology is the compression of the total run time to 6 minutes, which introduces an over three-fold increase in throughput compared to existing methods. The method was successfully validated according to ICH Q2(R2) , showing specificity, linearity (R2 = 0.998 within 70%–130% range), precision (%RSD ≤ 1.73%) and accurate recovery (98.8% – 100.2%) for bulk and final formulation samples.
- Open Access
- 9 August 2026
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 48 (8) , 805
Colloidal Light Scattering Distorts Fluorometric Quantification of mRNA in Lipid Nanoparticles
Accurate measurement of messenger RNA (mRNA) concentration and encapsulation efficiency remains a challenging task during mRNA-lipid nanoparticle (LNP) formulation development and quality control. RiboGreen-based fluorescence assays are often used for this purpose. LNP formulations are colloidal systems and may exhibit turbidity, which can interfere with fluorescence detection. The impact of LNP-related optical properties on assay performance remains insufficiently characterized. This study aimed to evaluate whether and how physicochemical factors associated with LNP-based drug-delivery systems influence fluorometric mRNA quantification. Empty LNPs, with the same lipid composition as mRNA-loaded LNPs, were used as a model matrix causing turbidity. Their effect on the RiboGreen fluorescence signal was assessed following dilution and then in different scenarios in the presence of free and encapsulated mRNA. The UV–Vis spectrum of the placebo dispersion was recorded to examine possible optical interference in the measurement range. We quantitatively characterized the suppression of fluorescence signals in the presence of LNPs in a concentration-dependent manner. These findings indicate that turbidity and LNP-associated matrix effects can bias RiboGreen-based mRNA quantification. To ensure reliable determination of mRNA concentration and accurate calculation of encapsulation efficiency in LNP formulations, method-specific dilution factors should be applied.
- 9 August 2026
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 48 (8) , 805
Open AccessColloidal Light Scattering Distorts Fluorometric Quantification of mRNA in Lipid Nanoparticles
Accurate measurement of messenger RNA (mRNA) concentration and encapsulation efficiency remains a challenging task during mRNA-lipid nanoparticle (LNP) formulation development and quality control. RiboGreen-based fluorescence assays are often used for this purpose. LNP formulations are colloidal systems and may exhibit turbidity, which can interfere with fluorescence detection. The impact of LNP-related optical properties on assay performance remains insufficiently characterized. This study aimed to evaluate whether and how physicochemical factors associated with LNP-based drug-delivery systems influence fluorometric mRNA quantification. Empty LNPs, with the same lipid composition as mRNA-loaded LNPs, were used as a model matrix causing turbidity. Their effect on the RiboGreen fluorescence signal was assessed following dilution and then in different scenarios in the presence of free and encapsulated mRNA. The UV–Vis spectrum of the placebo dispersion was recorded to examine possible optical interference in the measurement range. We quantitatively characterized the suppression of fluorescence signals in the presence of LNPs in a concentration-dependent manner. These findings indicate that turbidity and LNP-associated matrix effects can bias RiboGreen-based mRNA quantification. To ensure reliable determination of mRNA concentration and accurate calculation of encapsulation efficiency in LNP formulations, method-specific dilution factors should be applied.